Non-small-cell lung cancer

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
Lorenza Landi, Federica D’Incà, Alain Gelibter, Rita Chiari, Francesco Grossi, Angelo Delmonte, Antonio Passaro, Diego Signorelli, Francesco Gelsomino, Domenico Galetta, Diana Giannarelli, Hector Soto Parra, Gabriele Minuti, Marcello Tiseo, Maria Rita Migliorino, Francesco Cognetti, Luca Toschi, Paolo Bidoli, Francovito Piantedosi, Luana Calabro’, Federico Cappuzzo

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 316; DOI: 10.1186/s40425-019-0793-8
What have we learned from immunotherapy? Report from the 3rd and 4th meetings of the Campania Society of Oncology Immunotherapy (SCITO)
Paolo Antonio Ascierto, Giacomo Cartenì, Cesare Gridelli, Sandro Pignata, Antonio Pinto, Carmen Criscitiello, Luigi Buonaguro, Stefano Pepe, Roberto Mabilia, Vincenzo Montesarchio, Bruno Daniele, Sabino De Placido

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 41; DOI: 10.1186/s40425-016-0144-y
Immune-related response assessment during PD-1 inhibitor therapy in advanced non-small-cell lung cancer patients
Mizuki Nishino, Nikhil H. Ramaiya, Emily S. Chambers, Anika E. Adeni, Hiroto Hatabu, Pasi A. Jänne, F. Stephen Hodi, Mark M. Awad

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 84; DOI: 10.1186/s40425-016-0193-2

Main menu